内分泌疗法药市场:各药物类型，各应用领域，各流通管道，各地区- 规模，占有率，展望，机会分析，2022年～2030年

市场动态

预计糖尿病和乳腺癌等慢性病的增加、开发新型内分泌疗法 (ETD) 的研发活动增加，以及市场上主要参与者对无机增长战略（如收购和合作伙伴关係）的更多采用可望在预测期间内促进全球内分泌疗法药(ETD)市场成长。

本调查的主要特征

• 本报告提供以2021年为基准年的预测期间（2022-2030 年）之全球内分泌疗法药市场的市场规模和復合年增长率（CAGR %）相关的详细分析。
• 并阐明不同部门市场的潜在收入机会，说明该市场具有魅力的投资主张矩阵。
• 同时并提供市场推动因素和限制、机会、新产品发布或批准、市场趋势、区域前景和主要参与者采用的竞争战略等重要考察。
• 并基于企业亮点，各类型投资组合、主要焦点、财务业绩和市场策略等参数，介绍全球内分泌疗法药市场的主要参与者之企业简介。
• 藉由该报告提供的洞察，将能帮助营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
• 全球内分泌疗法药市场报告配合该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
• 利益相关者可以透过全球内分泌疗法药市场用于分析的各种战略矩阵来帮助他们更容易做下决策。

目录

第1章 调查目的与前提条件

• 调查目的
• 前提条件
• 简称的说明

第2章 市场展望

• 报告内容
  • 市场定义和范围
• 摘要整理
  • 市场明细:各药物类型
  • 市场明细:各应用领域
  • 市场明细:各流通管道
  • 市场明细，各地区
• 连贯机遇地图(COM)

第3章 市场动态，法规，趋势分析

• 市场动态
  • 促进因素
  • 阻碍因素
  • 市场机会
• 影响分析
• 开发平台分析
• PEST分析
• 法规情景
• 市场趋势
• 主要的焦点
• 保险偿付方案
• 企业合併·收购
• 流行病学

第4章 内分泌疗法药的全球市场- 冠状病毒(COVID-19)疫情的影响

• 经济影响
• 临床试验和医药品开发的影响
• 政府的配合措施

第5章 内分泌疗法药的全球市场:各药物类型，2017年～2030年

• 抗糖尿病药物
• 骨质疏鬆症治疗药
• 避孕药
• 乳癌治疗药
• 其他(更年期障碍治疗药等)

第6章 内分泌疗法药的全球市场:各用途，2017年～2030年

• 糖尿病治疗药
• 乳癌
• 骨质疏鬆症
• 更年期障碍
• 避孕
• 其他(变性手术，甲状腺机能低下症等)

第7章 内分泌疗法药的全球市场:各流通管道，2017年～2030年

• 医院内药局
• 零售药局
• 线上药局

第8章 内分泌疗法药的全球市场:各地区，2017年～2030年

• 北美
• 美国
• 加拿大
• 南美
• 巴西
• 墨西哥
• 阿根廷
• 其他的南美地区
• 欧洲
• 德国
• 英国
• 法国
• 义大利
• 西班牙
• 俄罗斯
• 其他的欧洲地区
• 亚太地区
• 中国
• 印度
• 日本
• 澳洲
• 韩国
• ASEAN
• 其他亚太地区
• 中东地区
• GCC
• 以色列
• 其他的中东地区
• 非洲
• 南非
• 中非
• 北非

第9章 竞争情形

• 热图分析
• 市场占有率分析
  • Novo Nordisk A/S
  • AstraZeneca
  • Generex Biotechnology
  • Orion Pharma AB
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.
  • F. Hoffmann-La Roche
  • Hisamitsu Pharmaceutical Co.,Inc.
  • Bayer AG
  • Eli Lilly and Company
  • Abbott
  • Tonghua Dongbao Pharmaceutical Co., Ltd.
  • Merck & Co., Inc.
  • TherapeuticsMD, Inc.
  • Pfizer Inc.
  • Allergan
  • BioSante Pharmaceuticals
  • Amgen Inc.
  • Noven Pharmaceuticals, Inc.
  • QuatRx Pharmaceuticals

第10章 章节

• 参考文献
• 调查手法的介绍

The endocrine system of the human body uses hormones to control and coordinate with the human body's metabolism, reproduction, energy level, growth and development, as well as response for stress, injury, and mood disorders. Endocrine therapy, also known as hormone therapy, adds, blocks, or removes hormones/chemicals in order to treat diseases such as breast cancer, diabetes, etc. Estrogen and progesterone found in a woman's body can aggravate breast cancer as these hormones help the cells grow and spread throughout the body. Two types of endocrine therapy can be used for the treatment of breast cancer, i.e. a) blocking the action of estrogen and progesterone to stop them from helping cancerous cells to grow and, b) using drugs or surgery to stop the ovary from producing estrogen and progesterone. Some of the endocrine therapy drugs used in breast cancer treatment include Abemaciclib (Verzenio), Anastrozole (Arimidex), Exemestane (Aromasin), and Fulvestrant (Faslodex), among others.

Market Dynamics

The increasing prevalence of chronic diseases such as diabetes, breast cancer, and others, rising research and development activities to develop novel endocrine therapy drugs (ETDs), and increasing adoption of inorganic growth strategies such as acquisitions and collaborations by key players operating in the market are the major factors that are expected to drive growth of the global endocrine therapy drugs (ETDs) market over the forecast period.

For instance, according to the International Federation of Diabetes Atlas 2019, around 463 million people aged 20-79 years and 136 million people aged 65 are estimated to be suffering from diabetes in 2019, globally. Moreover, according to the International Diabetes Federation Diabetes Atlas 2019, the prevalence of diabetes in Costa Rica is predicted to increase form 9.1 in 2019 to 10.3 by 2030.

Key features of the study:

• This report provides an in-depth analysis of the global endocrine therapy drugs (ETDs) market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global endocrine therapy drugs (ETDs) market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Novo Nordisk A/S, AstraZeneca, Generex Biotechnology, Orion Pharma AB, Sanofi, Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche, Hisamitsu Pharmaceutical Co.,Inc., Bayer AG, Eli Lilly and Company, Abbott, Tonghua Dongbao Pharmaceutical Co., Ltd., Merck & Co., Inc., TherapeuticsMD, Inc., Pfizer Inc., Allergan, BioSante Pharmaceuticals, Amgen Inc., Noven Pharmaceuticals, Inc., and QuatRx Pharmaceuticals
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global endocrine therapy drugs (ETDs) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global endocrine therapy drugs (ETDs) market

Detailed Segmentation:

• Global Endocrine Therapy Drugs (ETDs) Market, By Drug Type:
  • Anti-diabetic Drugs
  • Anti-osteoporosis Drugs
  • Contraceptive Drugs
  • Breast Cancer Drugs
  • Others (Menopause Drugs, among others)
• Global Endocrine Therapy Drugs (ETDs) Market, By Application:
  • Diabetes
  • Breast Cancer
  • Osteoporosis
  • Menopause
  • Contraception
  • Others (Gender Reassignment Surgery, Hypothyroidism, among others)
• Global Endocrine Therapy Drugs (ETDs) Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Global Endocrine Therapy Drugs (ETDs) Market, By Region:
  • North America
    • By Country
  • U.S.
  • Canada
  • Latin America
    • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Region
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Novo Nordisk A/S*
    • Company Overview
    • Material Portfolio
    • Financial Performance
    • Key Highlights
    • Market Strategies
  • AstraZeneca
  • Generex Biotechnology
  • Orion Pharma AB
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.
  • Hoffmann-La Roche
  • Hisamitsu Pharmaceutical Co.,Inc.
  • Bayer AG
  • Eli Lilly and Company
  • Abbott
  • Tonghua Dongbao Pharmaceutical Co., Ltd.
  • Merck & Co., Inc.
  • TherapeuticsMD, Inc.
  • Pfizer Inc.
  • Allergan
  • BioSante Pharmaceuticals
  • Amgen Inc.
  • Noven Pharmaceuticals, Inc.
  • QuatRx Pharmaceuticals

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Drug Type
  • Market Snippet, By Application
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Pipeline Analysis
• PEST Analysis
• Regulatory Scenario
• Market Trends
• Key Highlights
• Reimbursement Scenario
• Mergers & Acquisitions
• Epidemiology

4. Global Endocrine Therapy Drugs (ETDs) Market - Impact of Coronavirus (Covid-19) Pandemic

• Economic Impact
• Impact on Clinical Trials and Drug Development
• Government Initiatives

5. Global Endocrine Therapy Drugs (ETDs) Market, By Drug Type, 2017 - 2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Anti-diabetic Drugs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
• Anti-osteoporosis Drugs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
• Contraceptive Drugs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
• Breast Cancer Drugs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
• Others (Menopause Drugs, among others)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

6. Global Endocrine Therapy Drugs (ETDs) Market, By Application, 2017 - 2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Diabetes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
• Breast Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
• Osteoporosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
• Menopause
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
• Contraception
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
• Others (Gender Reassignment Surgery, Hypothyroidism, among others)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

7. Global Endocrine Therapy Drugs (ETDs) Market, By Distribution Channel, 2017 - 2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

8. Global Endocrine Therapy Drugs (ETDs) Market, By Region, 2017 - 2030, (US$ Mn)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2030
• North America
  • Market Size and Forecast, By Drug Type, 2017 - 2030, (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2030, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
• U.S.
• Canada
• Latin America
  • Market Size and Forecast, By Drug Type, 2017 - 2030, (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2030, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Market Size and Forecast, By Drug Type, 2017 - 2030, (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2030, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Market Size and Forecast, By Drug Type, 2017 - 2030, (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2030, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
  • Market Size and Forecast, By Drug Type, 2017 - 2030, (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2030, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Market Size and Forecast, By Drug Type, 2017 - 2030, (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2030, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
• South Africa
• Central Africa
• North Africa

9. Competitive Landscape

• Heat Map Analysis
• Market Share Analysis
  • Novo Nordisk A/S
• Company Overview
• Product Portfolio
• Financial Overview
• Key Highlights
• Market Strategies
  • AstraZeneca
  • Generex Biotechnology
  • Orion Pharma AB
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.
  • F. Hoffmann-La Roche
  • Hisamitsu Pharmaceutical Co.,Inc.
  • Bayer AG
  • Eli Lilly and Company
  • Abbott
  • Tonghua Dongbao Pharmaceutical Co., Ltd.
  • Merck & Co., Inc.
  • TherapeuticsMD, Inc.
  • Pfizer Inc.
  • Allergan
  • BioSante Pharmaceuticals
  • Amgen Inc.
  • Noven Pharmaceuticals, Inc.
  • QuatRx Pharmaceuticals
• Analyst Views

10. Section

• References
• Research Methodology
• About us and Sales Contact